Gemcitabine in Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by Denise A. Yardley

By Yardley Denise A.  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 334-335

Adis International

Access to resources Recommend Favorite

Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite

Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer

By Wist Erik Andreas   Sommer Hilde Heen   Østenstad Bjørn   Risberg Terje   Fjæstad Knut  

Acta Oncologica, Vol. 43, Iss. 1, 2004-03 ,pp. : 11-14

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer

By Yardley Denise A.   McCleod Michael   Schreiber Fred   Murphy Patrick   Patton Jeffrey   Thompson Dana S.   Shastry Mythili   Rubin Mark   Melnik Marianne   Burris Howard A.   Hainsworth John D.  

Cancer Investigation, Vol. 28, Iss. 9, 2010-10 ,pp. : 925-931

Informa Healthcare

Access to resources Recommend Favorite

First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

By Aogi Kenjiro   Masuda Norikazu   Ohno Shinji   Oda Takashi   Iwata Hiroji   Kashiwaba Masahiro   Fujiwara Yasuhiro   Kamigaki Shunji   Ito Yoshinori   Ueno Takayuki   Takashima Shigemitsu  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 829-838

Springer Publishing Company

Access to resources Recommend Favorite